FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
A Randomized, Double-blind, Placebo-Controlled Trial of Terminalia Chebula and Terminalia Bellerica For Hyperuricemia
Copy link
Facebook
Email
Notes
More

A Randomized, Double-blind, Placebo-Controlled Trial of Terminalia Chebula and Terminalia Bellerica For Hyperuricemia

Natural Products Offer Alternative to Allopurinol and Febuxostat for Gout

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
May 12, 2025
∙ Paid
70

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
A Randomized, Double-blind, Placebo-Controlled Trial of Terminalia Chebula and Terminalia Bellerica For Hyperuricemia
Copy link
Facebook
Email
Notes
More
5
14
Share
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

One of the great privileges of practicing medicine is the opportunity to learn from patients. I had a patient recently who told me a wonderful story of controlling gout flares by lowering uric acid in the blood naturally. I wondered if there were any randomized trial evidence.

Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia. Clin Pharmacol. 2016 Jun 22;8:51-9. doi: 10.2147/CPAA.S100521. PMID: 27382337; PMCID: PMC4922806.

Keep reading with a 7-day free trial

Subscribe to FOCAL POINTS (Courageous Discourse) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More